Intuitive Surgical, Inc. $ISRG Stock Sold by Philadelphia Trust Co.

Philadelphia Trust Co. trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.7% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 17,165 shares of the medical equipment provider’s stock after selling 1,231 shares during the period. Philadelphia Trust Co.’s holdings in Intuitive Surgical were worth $6,980,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of ISRG. Fairscale Capital LLC increased its holdings in shares of Intuitive Surgical by 3.5% in the 3rd quarter. Fairscale Capital LLC now owns 645 shares of the medical equipment provider’s stock valued at $279,000 after acquiring an additional 22 shares during the last quarter. Beaumont Financial Advisors LLC raised its position in shares of Intuitive Surgical by 3.8% during the 3rd quarter. Beaumont Financial Advisors LLC now owns 627 shares of the medical equipment provider’s stock valued at $255,000 after acquiring an additional 23 shares in the last quarter. Hughes Financial Services LLC raised its position in shares of Intuitive Surgical by 40.7% during the 3rd quarter. Hughes Financial Services LLC now owns 83 shares of the medical equipment provider’s stock valued at $37,000 after acquiring an additional 24 shares in the last quarter. W.G. Shaheen & Associates DBA Whitney & Co lifted its stake in Intuitive Surgical by 1.0% during the first quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 2,542 shares of the medical equipment provider’s stock worth $1,172,000 after purchasing an additional 25 shares during the last quarter. Finally, Blue Fin Capital Inc. lifted its stake in Intuitive Surgical by 0.5% during the first quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider’s stock worth $2,210,000 after purchasing an additional 25 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling

In other news, SVP Patricia Wadors sold 1,078 shares of the firm’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $443.80, for a total transaction of $478,416.40. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Mark Brosius sold 77 shares of Intuitive Surgical stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $375.57, for a total transaction of $28,918.89. Following the sale, the executive vice president owned 881 shares in the company, valued at approximately $330,877.17. This represents a 8.04% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 39,056 shares of company stock valued at $17,585,864. Company insiders own 0.60% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently commented on ISRG shares. Truist Financial decreased their price target on shares of Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating for the company in a report on Thursday, July 16th. Sanford C. Bernstein reiterated an “outperform” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. Leerink Partners set a $503.00 price objective on shares of Intuitive Surgical and gave the stock an “outperform” rating in a research note on Wednesday, October 21st. Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, October 31st. Finally, BTIG Research restated a “buy” rating and set a $454.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, October 21st. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $493.54.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $450.04 on Wednesday. Intuitive Surgical, Inc. has a 12-month low of $328.57 and a 12-month high of $603.88. The firm has a market capitalization of $156.00 billion, a price-to-earnings ratio of 54.42, a price-to-earnings-growth ratio of 3.17 and a beta of 1.45. The business has a 50 day simple moving average of $413.15 and a 200 day simple moving average of $431.20.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, beating the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The firm had revenue of $3.05 billion for the quarter, compared to the consensus estimate of $2.91 billion. During the same quarter in the previous year, the business earned $2.40 EPS. The firm’s revenue for the quarter was up 21.7% on a year-over-year basis. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.